LatAm / Megalabs: Playing Among Giants
The Top 15 pharmaceutical companies in the Central America and Caribbean (CENCA) market list is dominated by familiar big pharma players. However, among the liked of Sanofi, Abbott, Bayer, Pfizer,…
USA / Navigating Increasingly Stormy Market Access Waters
Certara’s Ulrich Neumann examines some of the major US market access trends of the past few years, including the innovative financing models required for novel therapies, why cost effectiveness considerations…
Europe / EUnetHTA's Uncertain Future & the Evolution of European HTA
The journey of EUnetHTA began back in 2004, when the European Commission and Council of Minsters requested the establishment of a sustainable European network on Health Technology Assessment (HTA) as…
Talent / Pharma Country Managers: The COVID Generation
While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive, working around the clock to ensure security of supply as…
France / ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal; AntiVax Struggles; Servier’s Neurology Push
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its in-house product and the…
Vaccines / Population Health: Access & Antivax Challenges
Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to clean water. It is estimated by global health institutions that vaccines save…
M&A / Viatris: Cost-Cutting Needed at New Generics Behemoth
In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and Pfizer’s Upjohn generics unit finally closed a USD 12 billion merger. The…
JP Morgan 2021 / A Course Correction for Future Meetings
David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual format, noting potential changes in format for future events. Crean does,…
China / 5 Top Trends in Healthcare & Biopharma in 2020
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being discovered in China around the beginning of 2020, the country bounced back…
Cell & Gene Therapy / Embryonic Gene Editing: How Far is Too Far to Find a Treatment for Your Child?
Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing. With CRISPR technology again in the news as part of the rush to develop…
APAC / Prestige & HH&L IPO News; Cold Chain Vaccine Challenges; Moderna Looks to CMOs
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L Acquisition; logistics challenges for COVID-19 vaccine distributors; and Moderna’s CMO-based vaccine manufacturing strategy in…
USA / What to Expect if Janet Woodcock Becomes Permanent FDA Head
Hours after President Biden was inaugurated on Tuesday 19th January 2021, Dr Janet Woodcock was named as acting commissioner for the Food and Drugs Administration (FDA). “The FDA’s public health…